US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
KR100291620B1
(ko)
*
|
1992-09-29 |
2001-10-24 |
추후제출 |
부갑상선호르몬의활성단편의폐를통한전달방법
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
KR100419037B1
(ko)
*
|
1994-03-07 |
2004-06-12 |
넥타르 테라퓨틱스 |
폐를통한인슐린의전달방법및그조성물
|
CN1073119C
(zh)
*
|
1994-05-18 |
2001-10-17 |
吸入治疗系统公司 |
干扰素干粉配方的方法及组合物
|
US6290991B1
(en)
*
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US6565885B1
(en)
*
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US6309623B1
(en)
*
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6598603B1
(en)
*
|
1997-12-31 |
2003-07-29 |
Astra Aktiebolag |
Method for treating respiratory diseases
|
GB9827145D0
(en)
*
|
1998-12-09 |
1999-02-03 |
Co Ordinated Drug Dev |
Improvements in or relating to powders
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
US6858199B1
(en)
*
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
DK2280020T3
(en)
*
|
1999-06-29 |
2016-05-02 |
Mannkind Corp |
Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
CA2387016C
(en)
*
|
1999-10-08 |
2010-09-28 |
William H. Miller |
Acrylamide derivatives as fab i inhibitors
|
WO2001032144A1
(en)
*
|
1999-10-29 |
2001-05-10 |
Inhale Therapeutic Systems, Inc. |
Dry powder compositions having improved dispersivity
|
US8820316B2
(en)
*
|
2000-02-11 |
2014-09-02 |
Respironics Respiratory Drug Delivery (Uk) Ltd |
Drug delivery apparatus
|
US8464706B2
(en)
*
|
2000-02-11 |
2013-06-18 |
Respironics Respiratory Drug Delivery (Uk) Ltd |
Drug delivery apparatus
|
PE20011227A1
(es)
*
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US7442388B2
(en)
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
WO2002000197A1
(en)
|
2000-06-27 |
2002-01-03 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
US20020106368A1
(en)
*
|
2000-07-28 |
2002-08-08 |
Adrian Bot |
Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same
|
JP2004515467A
(ja)
*
|
2000-08-07 |
2004-05-27 |
ネクター セラピューティックス |
吸入可能な、噴霧乾燥した、最少の凝集物を有する4−ヘリックスバンドルタンパク質粉末
|
US6677347B2
(en)
*
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
CA2432319A1
(en)
*
|
2000-12-21 |
2002-07-18 |
Nektar Therapeutics |
Pulmonary delivery of polyene antifungal agents
|
US7214364B2
(en)
*
|
2000-12-27 |
2007-05-08 |
Corus Pharma, Inc. |
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
|
US7138419B2
(en)
*
|
2000-12-27 |
2006-11-21 |
Corus Pharma, Inc. |
Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
|
IL156596A0
(en)
|
2000-12-27 |
2004-01-04 |
Salus Pharma Inc |
Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
WO2003088897A2
(en)
*
|
2001-04-06 |
2003-10-30 |
Affinium Pharmaceuticals, Inc. |
Fab i inhibitors
|
EP1392262A1
(de)
*
|
2001-05-24 |
2004-03-03 |
Alexza Molecular Delivery Corporation |
Verabreichung von arzneimittel-estern durch inhalation
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
WO2002094229A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of muscle relaxants through an inhalation route
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
EP1403371B1
(de)
*
|
2001-06-15 |
2007-03-28 |
Takeda Pharmaceutical Company Limited |
Polypeptid mit zelltodhemmender wirkung
|
EG24184A
(en)
*
|
2001-06-15 |
2008-10-08 |
Otsuka Pharma Co Ltd |
Dry powder inhalation system for transpulmonary
|
US20050123509A1
(en)
*
|
2001-10-19 |
2005-06-09 |
Lehrman S. R. |
Modulating charge density to produce improvements in the characteristics of spray-dried proteins
|
AU2002335046A1
(en)
*
|
2001-10-19 |
2003-05-06 |
Inhale Therapeutic Systems, Inc. |
The use of proton sequestering agents in drug formulations
|
AUPR879601A0
(en)
*
|
2001-11-09 |
2001-12-06 |
Biota Scientific Management Pty Ltd |
Novel chemical compounds and their use
|
CA2468958C
(en)
|
2001-12-19 |
2012-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US6900317B2
(en)
|
2002-02-19 |
2005-05-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
|
DE10206770A1
(de)
*
|
2002-02-19 |
2003-08-28 |
Boehringer Ingelheim Pharma |
Verfahren zur Herstellung eines Pulverinhalativums enthaltend ein Salz des CGRP-Antagonisten BIBN4096
|
US20040014679A1
(en)
*
|
2002-02-20 |
2004-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof
|
DE10207026A1
(de)
*
|
2002-02-20 |
2003-08-28 |
Boehringer Ingelheim Kg |
Pulverinhalativum, enthaltend den CGRP-Antagonisten BIBN4096 und Verfahren zu dessen Herstellung
|
JP2005520843A
(ja)
*
|
2002-03-20 |
2005-07-14 |
アドバンスト インハレーション リサーチ,インコーポレイテッド |
呼吸用持続性治療製剤
|
ES2300568T3
(es)
*
|
2002-03-20 |
2008-06-16 |
Mannkind Corporation |
Aparato de inhalacion.
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
ES2347239T3
(es)
*
|
2002-12-02 |
2010-10-27 |
Amgen Fremont Inc. |
Anticuerpos dirigidos al factor de necrosis tumoral y usos de los mismos.
|
EP1575951B1
(de)
*
|
2002-12-06 |
2014-06-25 |
Debiopharm International SA |
Heterozyclische verbindungen, verfahren zu deren herstellung und ihre verwendung als heilmittel
|
AR042454A1
(es)
*
|
2002-12-13 |
2005-06-22 |
Otsuka Pharma Co Ltd |
Sistema de inhalacion de polvo para la administracion transpulmonar
|
JP2004238392A
(ja)
*
|
2003-01-14 |
2004-08-26 |
Nipro Corp |
安定化された蛋白質性製剤
|
BRPI0407368A
(pt)
*
|
2003-02-10 |
2006-02-14 |
Bayer Healthcare Ag |
tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.
|
WO2004082586A2
(en)
|
2003-03-17 |
2004-09-30 |
Affinium Pharmaceuticals, Inc. |
Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
|
JP2007524607A
(ja)
*
|
2003-04-09 |
2007-08-30 |
ワイス |
凝固因子の吸入による血友病処置
|
EP1617845A4
(de)
*
|
2003-04-28 |
2006-09-20 |
3M Innovative Properties Co |
Zusammensetzungen und verfahren zur induktion von opioid-rezeptoren
|
EP1625334B9
(de)
|
2003-05-21 |
2012-07-25 |
Alexza Pharmaceuticals, Inc. |
Schlag gezündete unabhängige heizeinheit
|
EP1635786A2
(de)
*
|
2003-05-28 |
2006-03-22 |
Nektar Therapeutics |
Sprühtrocknung einer alkoholischen wässrigen lösung zur herstellung eines wasserunlöslichen wirkstoff-mikroteilchens mit einem teilweisen oder kompletten aminosäure- und/oder phospholipid-überzug
|
JP2007502293A
(ja)
*
|
2003-08-12 |
2007-02-08 |
スリーエム イノベイティブ プロパティズ カンパニー |
ヒドロキシルアミン置換イミダゾ含有化合物
|
DE10339197A1
(de)
*
|
2003-08-22 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
|
EP1658076B1
(de)
*
|
2003-08-27 |
2013-03-06 |
3M Innovative Properties Company |
Aryloxy- und arylalkylenoxy-substituierte imidazochinoline
|
CA2537763A1
(en)
*
|
2003-09-05 |
2005-03-17 |
3M Innovative Properties Company |
Treatment for cd5+ b cell lymphoma
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
WO2005025535A2
(en)
*
|
2003-09-15 |
2005-03-24 |
Vectura Limited |
Methods for preparing pharmaceutical compositions
|
AR046046A1
(es)
*
|
2003-10-03 |
2005-11-23 |
3M Innovative Properties Co |
Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
|
US20090075980A1
(en)
*
|
2003-10-03 |
2009-03-19 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and Analogs Thereof
|
US7544697B2
(en)
*
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
CA2545774A1
(en)
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Oxime substituted imidazo ring compounds
|
CA2545825A1
(en)
*
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazo ring compounds
|
BRPI0416936A
(pt)
*
|
2003-11-25 |
2007-01-16 |
3M Innovative Properties Co |
sistemas de anel de imidazo substituìdos e métodos
|
DE10358387A1
(de)
*
|
2003-12-13 |
2005-07-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
|
CN1925875A
(zh)
*
|
2003-12-16 |
2007-03-07 |
尼克塔治疗亚拉巴马公司 |
化学改性的小分子
|
US20060182692A1
(en)
|
2003-12-16 |
2006-08-17 |
Fishburn C S |
Chemically modified small molecules
|
EP1701955A1
(de)
*
|
2003-12-29 |
2006-09-20 |
3M Innovative Properties Company |
Arylalkenyl- und arylalkinylsubstituierte imidazochinoline
|
EP1699788A2
(de)
*
|
2003-12-30 |
2006-09-13 |
3M Innovative Properties Company |
Imidazochinolinyl-, imidazopyridinyl- und imidazonaphthyridinylsulfonamide
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
BRPI0418386A
(pt)
|
2003-12-31 |
2007-05-22 |
Cydex Inc |
formulação inalante contendo éter sulfoalquìlico gama-ciclodextrina e corticosteróide
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
EP1701714A2
(de)
|
2004-01-07 |
2006-09-20 |
Nektar Therapeutics |
Verbesserte zusammensetzungen mit verzögerter freisetzung für die pulmonale verabreichung von insulin
|
US20050153874A1
(en)
*
|
2004-01-12 |
2005-07-14 |
Mannkind Corporation |
Method of reducing serum proinsulin levels in type 2 diabetics
|
US7279457B2
(en)
*
|
2004-03-12 |
2007-10-09 |
Biodel, Inc. |
Rapid acting drug delivery compositions
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
DE602004023765D1
(de)
*
|
2004-03-12 |
2009-12-03 |
Trinity College Dublin |
Magnetoresistives medium
|
AU2005228150A1
(en)
*
|
2004-03-24 |
2005-10-13 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
SE528121C2
(sv)
*
|
2004-03-29 |
2006-09-05 |
Mederio Ag |
Preparering av torrpulver för på förhand uppmätt DPI
|
JP2007534693A
(ja)
|
2004-04-23 |
2007-11-29 |
サイデックス・インコーポレイテッド |
スルホアルキルエーテルシクロデキストリンを含有するdpi製剤
|
US20060039985A1
(en)
*
|
2004-04-27 |
2006-02-23 |
Bennett David B |
Methotrexate compositions
|
US7727962B2
(en)
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
US7723306B2
(en)
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
US7611709B2
(en)
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
PL1828167T3
(pl)
*
|
2004-06-04 |
2015-02-27 |
Debiopharm Int Sa |
Pochodne akryloamidu jako środki antybiotykowe
|
WO2005123080A2
(en)
*
|
2004-06-15 |
2005-12-29 |
3M Innovative Properties Company |
Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
WO2006065280A2
(en)
*
|
2004-06-18 |
2006-06-22 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
|
WO2006009826A1
(en)
*
|
2004-06-18 |
2006-01-26 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
WO2006038923A2
(en)
*
|
2004-06-18 |
2006-04-13 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
CN101027318B
(zh)
|
2004-07-19 |
2016-05-25 |
比奥孔有限公司 |
胰岛素-低聚物共轭物,制剂及其用途
|
WO2006033713A2
(en)
*
|
2004-08-09 |
2006-03-30 |
Chiron Corporation |
Methods for ciprofloxacin inhalation
|
CA2575692C
(en)
|
2004-08-20 |
2014-10-14 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
BR122019022692B1
(pt)
|
2004-08-23 |
2023-01-10 |
Mannkind Corporation |
Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
|
JPWO2006025395A1
(ja)
*
|
2004-08-31 |
2008-05-08 |
慶彦 清水 |
キャリアフリーの細胞増殖因子を用いた慢性閉塞性肺疾患に対する医薬および処置システム
|
US20090270443A1
(en)
*
|
2004-09-02 |
2009-10-29 |
Doris Stoermer |
1-amino imidazo-containing compounds and methods
|
EP1809252A2
(de)
*
|
2004-10-29 |
2007-07-25 |
Presidents and Fellows of Harvard College |
Partikel zu behandlung von lungeninfektion
|
WO2006063072A2
(en)
*
|
2004-12-08 |
2006-06-15 |
3M Innovative Properties Company |
Immunomodulatory compositions, combinations and methods
|
JP5543068B2
(ja)
*
|
2004-12-30 |
2014-07-09 |
スリーエム イノベイティブ プロパティズ カンパニー |
キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
|
US8034938B2
(en)
|
2004-12-30 |
2011-10-11 |
3M Innovative Properties Company |
Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
|
US9248127B2
(en)
*
|
2005-02-04 |
2016-02-02 |
3M Innovative Properties Company |
Aqueous gel formulations containing immune response modifiers
|
EP1846405A2
(de)
|
2005-02-11 |
2007-10-24 |
3M Innovative Properties Company |
Oxim- und hydroxylaminsubstituierte imidazo-4,5-c-ringverbindungen und verfahren
|
CA2602590A1
(en)
|
2005-04-01 |
2006-10-12 |
Coley Pharmaceutical Group, Inc. |
1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
|
US7943610B2
(en)
|
2005-04-01 |
2011-05-17 |
3M Innovative Properties Company |
Pyrazolopyridine-1,4-diamines and analogs thereof
|
PT1901749T
(pt)
|
2005-05-18 |
2016-11-04 |
Raptor Pharmaceuticals Inc |
Fluoroquinolonas aerossolizadas e suas utilizações
|
US8546423B2
(en)
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US7838532B2
(en)
|
2005-05-18 |
2010-11-23 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
HUE028691T2
(en)
|
2005-09-14 |
2016-12-28 |
Mannkind Corp |
A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
ITMI20051999A1
(it)
|
2005-10-21 |
2007-04-22 |
Eratech S R L |
Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
WO2007067416A2
(en)
*
|
2005-12-05 |
2007-06-14 |
Affinium Pharmaceuticals, Inc. |
Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
|
EP1968644B1
(de)
|
2005-12-16 |
2012-06-27 |
Nektar Therapeutics |
Polymerkonjugate von glp-1
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
CN101389313A
(zh)
*
|
2006-02-10 |
2009-03-18 |
帕锐制药两和公司 |
用于吸入疗法的雾化抗生素
|
EP1986674A4
(de)
*
|
2006-02-13 |
2009-11-11 |
Nektar Therapeutics |
Methioninhaltige protein- oder peptidzusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
|
CA2642577A1
(en)
*
|
2006-02-15 |
2007-08-23 |
Tika Lakemedel Ab |
Methods of manufacturing corticosteroid solutions
|
EP1986679B1
(de)
|
2006-02-22 |
2017-10-25 |
MannKind Corporation |
Verfahren zur verbesserung der pharmazeutischen eigenschaften von mikropartikeln mit diketopiperazin und einem wirkstoff
|
JP2009533471A
(ja)
*
|
2006-04-12 |
2009-09-17 |
バイオデル, インコーポレイテッド |
即効型および長時間作用型組合せインスリン製剤
|
ES2386972T3
(es)
*
|
2006-05-31 |
2012-09-10 |
Genzyme Corporation |
Uso de polisacáridos para la estimulación de la actividad enzimática
|
WO2008008432A2
(en)
*
|
2006-07-12 |
2008-01-17 |
Coley Pharmaceutical Group, Inc. |
Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
|
EP2054422B1
(de)
|
2006-07-20 |
2017-06-14 |
Debiopharm International SA |
Acrylamidderivate als fab-i-inhibitoren
|
FR2904532B1
(fr)
*
|
2006-08-03 |
2012-10-19 |
Soc Extraction Principes Actif |
Composition dermatologique et/ou cosmetique contenant des polypeptides ou des peptides
|
EP2066341B1
(de)
*
|
2006-09-01 |
2015-07-15 |
CSL Limited |
Verfahren zur auslösung oder einleitung einer immunantwort
|
WO2008025560A1
(en)
*
|
2006-09-01 |
2008-03-06 |
Pari Pharma Gmbh |
Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
|
EP3255045A1
(de)
*
|
2007-02-16 |
2017-12-13 |
Debiopharm International SA |
Salze, prodrugs und polymorphe von fab i-inhibitoren
|
US20080216828A1
(en)
|
2007-03-09 |
2008-09-11 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
WO2008137747A1
(en)
|
2007-05-02 |
2008-11-13 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
WO2009002481A1
(en)
*
|
2007-06-26 |
2008-12-31 |
Merck & Co., Inc. |
Lyophilized anti-fungal composition
|
CA2702094C
(en)
|
2007-10-10 |
2018-05-01 |
Parion Sciences, Inc. |
Delivering osmolytes by nasal cannula
|
SG185294A1
(en)
*
|
2007-10-12 |
2012-11-29 |
Csl Ltd |
Method of eliciting an immune response against pandemic influenza virus
|
CN101951957A
(zh)
*
|
2008-01-04 |
2011-01-19 |
百达尔公司 |
胰岛素释放作为组织的葡萄糖水平的函数的胰岛素制剂
|
WO2009120619A2
(en)
*
|
2008-03-24 |
2009-10-01 |
Novartis Ag |
Nuclease compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
|
WO2009143011A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Novartis Ag |
Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
AR072114A1
(es)
|
2008-06-13 |
2010-08-04 |
Mannkind Corp |
Un inhalador de polvo seco y sistema para suministro de farmacos
|
BRPI0914308B8
(pt)
|
2008-06-20 |
2021-06-22 |
Mannkind Corp |
sistema de inalação
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
MX2011003117A
(es)
*
|
2008-09-19 |
2011-04-21 |
Nektar Therapeutics |
Conjugados polimericos de peptidos terapeuticos.
|
EP2344200A2
(de)
*
|
2008-09-19 |
2011-07-20 |
Nektar Therapeutics |
Modifizierte therapeutische peptide, herstellungsverfahren und verwendung
|
WO2010036938A2
(en)
*
|
2008-09-26 |
2010-04-01 |
Nanobio Corporation |
Nanoemulsion therapeutic compositions and methods of using the same
|
HUE050147T2
(hu)
|
2008-10-07 |
2020-11-30 |
Horizon Orphan Llc |
Tüdõgyulladás csökkentése levofloxacin belélegzése útján
|
MX345158B
(es)
|
2008-10-07 |
2017-01-18 |
Raptor Pharmaceuticals Inc |
Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada.
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
EP3184099A1
(de)
|
2009-03-26 |
2017-06-28 |
Pulmatrix, Inc. |
Trockenpulverformulierungen und verfahren zur behandlung von lungenerkrankungen
|
US9539233B2
(en)
*
|
2009-05-04 |
2017-01-10 |
Aridis Pharmaceuticals Inc. |
Gallium formulation for the treatment and prevention of infectious diseases
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
TWI695723B
(zh)
|
2009-05-29 |
2020-06-11 |
美商沛爾醫療股份有限公司 |
用於經由呼吸道輸送活性劑的組成物以及相關方法與系統
|
WO2010142017A1
(en)
|
2009-06-09 |
2010-12-16 |
Defyrus, Inc . |
Administration of interferon for prophylaxis against or treatment of pathogenic infection
|
KR101875969B1
(ko)
|
2009-06-12 |
2018-07-06 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
AU2010289326B2
(en)
|
2009-09-04 |
2015-09-24 |
Horizon Therapeutics U.S. Holding Llc |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
EP2496295A1
(de)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
|
US9072783B2
(en)
|
2009-11-18 |
2015-07-07 |
Aridis Pharmaceuticals |
Highly dispersible powders, compositions and methods for preparation
|
US20110233469A1
(en)
*
|
2009-12-21 |
2011-09-29 |
Brent Petersen |
Leucine/Peptide Composition and Method of Formulation
|
DK2947148T3
(en)
|
2010-04-20 |
2017-09-18 |
Octapharma Ag |
NEW STABILIZER FOR PHARMACEUTICAL PROTEINS
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
WO2012030647A1
(en)
|
2010-08-30 |
2012-03-08 |
Pulmatrix, Inc. |
Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
|
US9061352B2
(en)
|
2010-08-30 |
2015-06-23 |
Pulmatrix, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
WO2012050945A1
(en)
|
2010-09-29 |
2012-04-19 |
Pulmatrix, Inc. |
Cationic dry powders
|
WO2012044736A1
(en)
|
2010-09-29 |
2012-04-05 |
Pulmatrix, Inc. |
Monovalent metal cation dry powders for inhalation
|
AU2011336410B2
(en)
|
2010-12-02 |
2015-01-22 |
Oncolytics Biotech Inc. |
Lyophilized viral formulations
|
WO2012075379A2
(en)
|
2010-12-02 |
2012-06-07 |
Oncolytics Biotech Inc. |
Liquid viral formulations
|
WO2012094381A2
(en)
|
2011-01-05 |
2012-07-12 |
Hospira, Inc. |
Spray drying vancomycin
|
CA2824432C
(en)
|
2011-01-31 |
2021-10-19 |
Genoa Pharmaceuticals, Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
US10358043B2
(en)
*
|
2011-03-31 |
2019-07-23 |
Elite Power Solutions, LLC |
Golf cart battery system
|
JP6133270B2
(ja)
|
2011-04-01 |
2017-05-24 |
マンカインド コーポレイション |
薬剤カートリッジのためのブリスター包装
|
US9572774B2
(en)
|
2011-05-19 |
2017-02-21 |
Savara Inc. |
Dry powder vancomycin compositions and associated methods
|
AU2012254999B2
(en)
*
|
2011-05-19 |
2016-02-11 |
Savara, Inc. |
Dry powder vancomycin compositions and associated methods
|
KR101792473B1
(ko)
*
|
2011-06-07 |
2017-10-31 |
아사히 가세이 파마 가부시키가이샤 |
고순도 pth 함유 동결 건조 제제 및 그의 제조 방법
|
JP6219271B2
(ja)
|
2011-06-07 |
2017-10-25 |
パリオン・サイエンシィズ・インコーポレーテッド |
治療の方法
|
US8945605B2
(en)
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
JP6018640B2
(ja)
|
2011-10-24 |
2016-11-02 |
マンカインド コーポレイション |
疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム
|
CA2858247A1
(en)
|
2011-12-16 |
2013-06-20 |
Novartis Ag |
Aerosolization apparatus for inhalation profile-independent drug delivery
|
NZ629722A
(en)
|
2012-02-29 |
2017-03-31 |
Pulmatrix Operating Co Inc |
Inhalable dry powders
|
KR101342485B1
(ko)
*
|
2012-02-29 |
2013-12-17 |
미원상사주식회사 |
트리펩타이드 및 이를 함유하는 노화방지, 주름개선, 미백 및 항염효능의 화장료 조성물
|
SG11201407676VA
(en)
*
|
2012-05-21 |
2015-03-30 |
Agency Science Tech & Res |
A dry powder formulation
|
EP3366680B1
(de)
|
2012-05-29 |
2020-05-13 |
Parion Sciences, Inc. |
Dendrimerähnliche aminoamide mit natriumkanalblockeraktivität zur behandlung von xerophthalmie und anderen schleimhauterkrankungen
|
JP6085026B2
(ja)
|
2012-06-19 |
2017-02-22 |
デビオファーム インターナショナル エスエーDebiopharm International Sa |
(e)−n−メチル−n−((3−メチルベンゾフラン−2−イル)メチル)−3−(7−オキソ−5,6,7,8−テトラヒドロ−1,8−ナフチリジン−3−イル)アクリルアミドのプロドラッグ誘導体
|
SG11201500218VA
(en)
|
2012-07-12 |
2015-03-30 |
Mannkind Corp |
Dry powder drug delivery systems and methods
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
BR112015014349A2
(pt)
|
2012-12-17 |
2017-07-11 |
Parion Sciences Inc |
derivados de cloro-pirazina carboxamida úteis para o tratamento de doenças favorecidas por hidratação mucosa insuficiente
|
ES2674665T3
(es)
|
2012-12-17 |
2018-07-03 |
Parion Sciences, Inc. |
Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
|
BR112015014178A2
(pt)
|
2012-12-17 |
2017-07-11 |
Parion Sciences Inc |
compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
|
WO2014144895A1
(en)
|
2013-03-15 |
2014-09-18 |
Mannkind Corporation |
Microcrystalline diketopiperazine compositions and methods
|
CN104043104B
(zh)
|
2013-03-15 |
2018-07-10 |
浙江创新生物有限公司 |
含盐酸万古霉素的喷雾干粉及其工业化制备方法
|
US20140275517A1
(en)
|
2013-03-15 |
2014-09-18 |
Pearl Therapeutics, Inc. |
Methods and systems for conditioning of particulate crystalline materials
|
JP6473738B2
(ja)
|
2013-04-01 |
2019-02-20 |
パルマトリックス,インコーポレイテッド |
チオトロピウム乾燥粉末
|
JP2016519160A
(ja)
|
2013-05-22 |
2016-06-30 |
パール セラピューティクス,インコーポレイテッド |
3つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム
|
AU2014290438B2
(en)
|
2013-07-18 |
2019-11-07 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
AU2014296032A1
(en)
|
2013-07-31 |
2016-03-17 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
WO2015021064A1
(en)
|
2013-08-05 |
2015-02-12 |
Mannkind Corporation |
Insufflation apparatus and methods
|
JP7066321B2
(ja)
|
2014-01-10 |
2022-05-13 |
アヴァリン ファーマ インク. |
エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
ES2924988T3
(es)
|
2014-10-10 |
2022-10-13 |
Univ Michigan Regents |
Composiciones con nanoemulsiones para prevenir, inhibir o eliminar una enfermedad alérgica e inflamatoria
|
US10751351B2
(en)
|
2016-02-26 |
2020-08-25 |
Debiopharm International S.A. |
Medicament for treatment of diabetic foot infections
|
EP3478264A1
(de)
*
|
2016-06-30 |
2019-05-08 |
Philip Morris Products S.a.s. |
Nikotinpartikel und zusammensetzungen
|
BR112019008063A2
(pt)
|
2016-10-21 |
2019-07-02 |
Adimab Llc |
anticorpos contra o vírus sincicial anti-respiratório e métodos de sua geração e uso
|
WO2018075954A2
(en)
|
2016-10-21 |
2018-04-26 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
JP2020503843A
(ja)
|
2016-10-21 |
2020-02-06 |
アディマブ, エルエルシー |
抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法
|
CN106727348B
(zh)
*
|
2016-12-20 |
2020-10-13 |
广州中大南沙科技创新产业园有限公司 |
防潮抗湿的低密度载体颗粒及其制备方法和应用
|
EP3559016A1
(de)
*
|
2016-12-23 |
2019-10-30 |
University of Copenhagen |
Co-amorphe form einer substanz und eines dipeptids
|
CN114867748A
(zh)
|
2019-10-28 |
2022-08-05 |
免疫医疗有限公司 |
结合胸腺基质淋巴细胞生成素(tslp)的抗体的干粉制剂及其使用方法
|
CN114599348A
(zh)
*
|
2019-10-28 |
2022-06-07 |
阿斯利康(瑞典)有限公司 |
含亮氨酸和三亮氨酸的干粉配制品
|
TW202241410A
(zh)
*
|
2021-01-08 |
2022-11-01 |
大陸商江蘇恒瑞醫藥股份有限公司 |
可經由定量吸入器遞送的藥物組合物
|
KR20240042438A
(ko)
|
2021-07-09 |
2024-04-02 |
아스트라제네카 파마수티컬스 엘피 |
에어로졸 약물 전달을 위한 조성물, 방법 및 시스템
|
US20230053812A1
(en)
*
|
2021-07-27 |
2023-02-23 |
Aurobindo Pharma Ltd |
Stable peptide formulations for oral use
|
WO2023091081A2
(en)
*
|
2021-11-16 |
2023-05-25 |
Agency For Science, Technology And Research |
Inhalable recombinant protein powder formulation for treating genetic and autoimmune disorders
|
WO2023119093A1
(en)
|
2021-12-20 |
2023-06-29 |
Astrazeneca Ab |
Compositions, methods and systems for aerosol drug delivery
|
WO2023212191A1
(en)
|
2022-04-28 |
2023-11-02 |
Astrazeneca Ab |
Combination of albuterol and budesonide for the treatment of asthma
|
WO2023229023A1
(ja)
*
|
2022-05-25 |
2023-11-30 |
学校法人 名城大学 |
粉末剤及びその製造方法
|